AIMS: To investigate associations between gamma-glutamyltransferase (GGT) and components of metabolic syndrome (MS), insulin resistance and inflammatory markers in the Korean population. METHODS: The 3508 subjects enrolled in this survey participated in the Korean Rural Genomic Cohort (KRGC) study. Written consent was obtained from the local ethical committee. Of these participants, 1437 were men (mean age 56.9 +/- 7.9 years) and 2071 were women (mean age 55.8 +/- 8.1 years). We measured GGT levels and various biochemical markers. To examine insulin resistance status, we used the homeostasis assessment method for insulin resistance (HOMA-IR). For inflammatory marker, we used C-reactive protein (CRP) levels. RESULTS: Serum GGT levels were significantly higher in the MS group compared to the healthy patient group [23 (5-1403) vs. 19 (5-1920) IU/l; P = 0.01]. The prevalence of MS and adjusted relative risk were both significantly increased from the lowest to highest GGT quartiles; these results persisted after adjustments for multiple confounders. Positive correlations were established between GGT and HOMA-IR or CRP. CONCLUSION: These results suggest that GGT levels may be a surrogate marker of insulin resistance, inflammation and MS.
AIMS: To investigate associations between gamma-glutamyltransferase (GGT) and components of metabolic syndrome (MS), insulin resistance and inflammatory markers in the Korean population. METHODS: The 3508 subjects enrolled in this survey participated in the Korean Rural Genomic Cohort (KRGC) study. Written consent was obtained from the local ethical committee. Of these participants, 1437 were men (mean age 56.9 +/- 7.9 years) and 2071 were women (mean age 55.8 +/- 8.1 years). We measured GGT levels and various biochemical markers. To examine insulin resistance status, we used the homeostasis assessment method for insulin resistance (HOMA-IR). For inflammatory marker, we used C-reactive protein (CRP) levels. RESULTS: Serum GGT levels were significantly higher in the MS group compared to the healthy patient group [23 (5-1403) vs. 19 (5-1920) IU/l; P = 0.01]. The prevalence of MS and adjusted relative risk were both significantly increased from the lowest to highest GGT quartiles; these results persisted after adjustments for multiple confounders. Positive correlations were established between GGT and HOMA-IR or CRP. CONCLUSION: These results suggest that GGT levels may be a surrogate marker of insulin resistance, inflammation and MS.
Authors: Hyo Jeong Oh; Tae Hyeon Kim; Young Woo Sohn; Yong Sung Kim; Yong Reol Oh; Eun Young Cho; So Yeon Shim; Sae Ron Shin; A Lum Han; Seok Jin Yoon; Haak Cheoul Kim Journal: Korean J Hepatol Date: 2011-03
Authors: Yoon Jin Choi; Dong Ho Lee; Kyung-Do Han; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim Journal: PLoS One Date: 2017-05-05 Impact factor: 3.240
Authors: Dhananjay Yadav; Mi Young Lee; Jang Young Kim; Hoon Ryu; Ji Hye Huh; Keum Seok Bae; Song Vogue Ahn; Choon Hee Chung; Jong Taek Park; Sang Baek Koh Journal: Yonsei Med J Date: 2017-07 Impact factor: 2.759
Authors: Mi Young Lee; Dae Sung Hyon; Ji Hye Huh; Hae Kyung Kim; Sul Ki Han; Jang Young Kim; Sang Baek Koh Journal: Endocrinol Metab (Seoul) Date: 2019-12